The ratio of patients with high POLD1 mRNA expression was 8%, and high POLD1 expression was associated with worse Progression Free Survival (PFS) in patients with endometrial cancer (Supplementary Fig. 3e, f). Here, POLD1 is linked to endometrial cancer.